Ginsenoside Rg3 reduces obesity-induced insulin resistance and lipotoxicity through signal transducer and activator of transcription 5 (STAT5)-PPAR-γ (Lee et al., 2017). Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.